- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Infrared Sciences trolls for buyer
Other headlines:iCAD installs MR image analysis softwareZiosoft shows new capabilities in Japan
iCAD installs MR image analysis software
A computer-aided detection system that identifies early signs of prostate cancer has begun operating at Research Medical Center in Kansas City, MO. VividLook by iCAD helps differentiate benign from malignant tumors, while locating and sizing tumors. The Kansas City site is the first installation of the product since iCAD last year purchased the developer of the software, CAD Sciences.
Ziosoft shows new capabilities in Japan
Visualization specialist Ziosoft unveiled new tools for its thin-client Ziostation system at the International Technical Exhibition of Medical Imaging April 17 to 19 in Yokohama, Japan. Among them were a SPECT/CT fusion application, MR cardiac function analysis, and 4D brain perfusion showing dynamic analyses using data from Toshiba's 320-slice CT scanner, none of which is yet available for sale in the U.S. Also featured at the Japanese conference was a load-balancing concept for clustering servers, as well as the new zioTerm free 2D and pay-per-study 3D application model aimed at academic users. Accessibility to medical images was further exemplified by proof-of-concept iPhone applications.
Infrared Sciences trolls for buyer
The maker of an infrared detector of breast cancer wants out. Infrared Sciences, manufacturer of the Sentinel BreastScan, is looking for a "strategic acquirer" interested in buying either the company or its assets. Infrared Sciences began putting out feelers last week after announcing the publication of a clinical study of the Sentinel BreastScan at Weill Medical College of Cornell University in the American Journal of Surgery. Company president and CEO Thomas DiCicco cited the current economic climate and lack of investment capital as keeping Infrared Sciences from securing the necessary investment funds to sustain the operation and grow the company.
"This will result in the company being forced to cease operation in the next few months," he said.
He urged "interested parties to contact the company as soon as possible."
Mammography and Breast MRI: Is it Time to Evaluate Strategies as Opposed to Modalities?
July 5th 2024The combination of mammography with breast MRI within 90 days had a 96.2 percent sensitivity in comparison to 48.1 percent for mammography and 79.7 percent for breast MRI performed within 91 to 270 days after index mammography, according to newly published research.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.
